81 results about "Acute injury" patented technology

Substantially homogenous cells populations which co-express CD49c, CD90 and telomerase are made. In one embodiment, humans suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition are treated with the substantially homogenous cells populations which co-express CD49c, CD90 and telomerase. In another embodiment, committed progenitor cells are made are made by selecting from a cultured source of a cell population which co-express CD49c and CD90 and modifying the cell population. The committed progenitor cells can be employed to treat a human suffering from a degenerative, traumatic, acute injury cardiac or neurological condition and formulate pharmaceutical compositions.

A method to speed recovery from acute injury and / or reduce and prevent chronic inflammation in an animal or human is disclosed. The method includes providing a grounded plane, conductively coupling said animal or human to the grounded plane to conduct the earth's mobile negative surface charge of free electrons from the earth to said animal or human in order to provide the body with an abundant supply of free electrons to reduce residual immune system produced reactive oxygen specie free radicals and prevent the same from oxidizing healthy tissue and exhibiting chronic inflammation in said animal or man. Applying earth's free electrons to the human body for prevention of chronic inflammation and therapeutic reduction of inflammation is described. Further described are methods to apply and maintain earth's mobile free electron charge on an animal or human while residing in modern home or work environments or in a treatment facility.

The invention relates to a bacterial cellulose (BC) based antibacterial dry film applied to acute injury, comprising the following components of a BC dry film and an antibacterial agent, wherein the drug loading rate of the BC based antibacterial dry film is 0.0114-0.2027mg / cm<2>. A preparation method of the BC based antibacterial dry film comprises the steps of: after implanting production strains of the BC into a seed culture medium for spreading cultivation, transplanting the strains to a fermentation medium for static culture, obtaining a BC wet film for soaking and water-bath treatment, cutting the wet film into sheets for drying, dipping the sheets in a pre-prepared antibacterial agent solution for secondary drying to obtain the BC based antibacterial dry film. In the invention, the BC based antibacterial dry film has the advantages of light and soft texture, good biocompatibility, high hygroscopicity, good air permeability, long-lasting antibiotic property and the like; in addition, the preparation method is simple, convenient and easy in operation and has low cost; in the practical application process, the BC based antibacterial dry film can be sheared into any shape, is not adhesive, has no irritation on skin, can be rapidly degraded in the environment after being abandoned, and can be taken as a green and environment-friendly functional antibacterial dressing.

The invention discloses a composition for treating acute injury of soft tissue. The composition is prepared from Chinese angelica, divaricate saposhnikovia root, hovenia dulcis, thunberg fritillary bulb, anemarrhena, rhizoma arisaematis (processed), snakegourd fruit, angelia and safflower. The composition disclosed by the invention has the effects of regulating qi, activating blood and resolving stasis and subsiding swelling and reliving pain, is used for treating acute injury of the soft tissues such as chest, waist and back, limbs and the like, and can be made into capsules which are convenient to carry and use by the patients. The composition disclosed by the invention is proved to be safe and effective by pharmacodynamics and toxicological experiments as well as clinical trials.

The invention relates to a low-damage implanted nerve electrode. The low-damage implanted nerve electrode comprises a base portion, a connecting portion and a handle portion; flexible hinges are connected between the base portion and the connecting portion; and one end of the handle portion is connected with the connecting portion. According to the low-damage implanted nerve electrode of the invention, the base is designed based on a flexible mechanism design ideal, and therefore, coupling degree between the electrode and an brain tissue interface can be enhanced, and fretting damage caused by long-term contact between the electrode and a nerve tissue can be decreased in a multi-degree-of-freedom manner; the front end of the handle is designed to a semicircle corner, so that fretting damage can be further reduced; and the exterior of the electrode is provided with an outwards-protruding streamline degradable coating, so that electrode implantation damage can be reduced. The implantation shape of the electrode and the fretting working state shape of the electrode do not interfere each other; acute injuries are smaller when the electrode is implanted; when the electrode works for a long time, fretting damage can be decreased in a plurality of directions; damage to nerve cells can be decreased through the integration of many aspects; the reliability of the micro electrode can be improved; and the nerve electrode can be left in vivo for a long term stably.

The invention relates to a medical cold compress bandage and a production method thereof. The medical cold compress bandage consists of a cold compress agent and a fabric for carrying the cold compress agent, wherein the cold compress agent consists of borneol, camphor, menthol and derivatives of menthol, N,2,3-trimethyl-2-isopropyl butyrylamide, plant essential oil, glycerol, ethanol, a thickening agent, a solubilizing agent and a preservative. The medical cold compress bandage provided by the invention is preserved at normal temperature, is convenient to carry and convenient and safe to use, and can last for more than 2 hours at once cold compress; the medical cold compress bandage provided by the invention has the functions of pressurizing, binding and fixation, has a good effect on detumescence, pain relieving and hemostasis in cold compress 48 hours before surgery of noninvasive acute injury and closed fracture, and the pain relieving effect is superior to that of an ice bag.

We disclose a new and useful biomarker for acute kidney injury (i.e., AKI), renal ischemia reperfusion injury (i.e., IRI), ischemic acute kidney injury, and / or ischemic acute tubular necrosis (i.e., ATN). The biomarker is GRO-alpha (i.e., CXCL1, chemokine C-X-C ligand 1, GRO1, GROa, MGSA, MGSA alpha, MGSA-a, NAP-3, SCYB1). We detected the biomarker using a QUANTIKINE® human GRO-alpha immunoassay (Cat. No. DGR00, R & D Systems, Minneapolis, Minn.). In addition, we disclose a method of treating lung damage.

Novel non-psychotropic cannabinoids are disclosed and pharmaceutical compositions comprising these novel compounds are described for preventing neurotoxicity, neuroinflammation, immune or inflammatory disorders comprising as active ingredient the stereospecific (+) enantiomer, having (3S,4S) configuration of Δ6 tetrahydrocannabinol type compounds. The compositions are particularly effective in alleviating and even preventing neurotoxicity due to acute injuries to the central nervous system, including mechanical trauma, compromised or reduced blood supply as may occur in cardiac arrest or stroke, or poisonings. They are also effective in the treatment of certain inflammatory disorders and chronic degenerative diseases characterized by neuronal loss and chronic pain including neuropathic pain.

The invention relates to a medical cold compress bandage and a production method thereof. The medical cold compress bandage consists of a cold compress agent and a fabric for carrying the cold compress agent, wherein the cold compress agent consists of borneol, camphor, menthol and derivatives of menthol, N,2,3-trimethyl-2-isopropyl butyrylamide, plant essential oil, glycerol, ethanol, a thickening agent, a solubilizing agent and a preservative. The medical cold compress bandage provided by the invention is preserved at normal temperature, is convenient to carry and convenient and safe to use, and can last for more than 2 hours at once cold compress; the medical cold compress bandage provided by the invention has the functions of pressurizing, binding and fixation, has a good effect on detumescence, pain relieving and hemostasis in cold compress 48 hours before surgery of noninvasive acute injury and closed fracture, and the pain relieving effect is superior to that of an ice bag.